Medigene AG (ETR:MDG1)
0.1335
-0.0510 (-27.64%)
Apr 29, 2025, 5:36 PM CET
Medigene AG Revenue
Medigene AG had revenue of 1.46M EUR in the quarter ending June 30, 2024, a decrease of -6.00%. This brings the company's revenue in the last twelve months to 7.45M, down -17.51% year-over-year. In the year 2023, Medigene AG had annual revenue of 6.03M, down -80.69%.
Revenue (ttm)
7.45M
Revenue Growth
-17.51%
P/S Ratio
0.26
Revenue / Employee
85.59K
Employees
76
Market Cap
1.97M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.03M | -25.21M | -80.69% |
Dec 31, 2022 | 31.25M | 20.78M | 198.64% |
Dec 31, 2021 | 10.46M | 2.46M | 30.75% |
Dec 31, 2020 | 8.00M | -2.51M | -23.87% |
Dec 31, 2019 | 10.51M | 2.94M | 38.74% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 23.14B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Medigene AG News
- 3 months ago - Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S. - Wallstreet:Online
- 3 months ago - Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S. - GlobeNewsWire
- 3 months ago - Medigene AG announces closing of its first SEPA tranche - GlobeNewsWire
- 3 months ago - IRW-News: Medigene AG: Medigene AG übt erste Tranche des Standby Equity Purchase Agreements aus - Onvista
- 5 months ago - Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers - GlobeNewsWire
- 6 months ago - KPMG: 94% of Life Sciences CEOs to Expand Workforce Over the Next 3 Years - CEOWORLD magazine
- 7 months ago - Medigene AG reports Q3 results - Seeking Alpha
- 8 months ago - Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021 - GlobeNewsWire